Why is Orchid Pharma falling/rising?

As of 06-Aug, Orchid Pharma Ltd's stock price is currently at 758.55, reflecting a decline of 30.85 points, or 3.91%. The stock has been underperforming, having lost 5.28% over the last two days, and it touched an intraday low of Rs 749.95. Additionally, the stock has experienced a significant year-to-date decline of 58.26%, despite a strong performance over the past three years with a return of 142.43%. The stock's recent performance has also been negatively impacted by a decrease in investor participation, with delivery volume falling by 24.98% against the five-day average, indicating reduced interest from investors.
In the broader market context, the pharmaceutical and drugs sector has also seen a decline, with a drop of 2.17%. While Orchid Pharma has outperformed the Sensex over the past week with a return of 7.23% compared to the benchmark's -1.15%, the stock's overall performance remains concerning due to its substantial year-to-date and one-year losses. The stock's moving averages indicate that it is currently lower than the 200-day moving average, which may suggest a bearish trend in the longer term. Overall, the combination of sector-wide declines, falling investor participation, and the stock's recent consecutive losses contribute to its current downward movement.